Literature DB >> 8145618

Intraoperative monitoring of intact PTH during surgery for primary hyperparathyroidism.

A Bergenfelz1, A Isaksson, B Ahrén.   

Abstract

The intraoperative differential diagnosis between adenoma and hyperplasia during surgery for primary hyperparathyroidism (pHPT) is sometimes difficult. Several methods have been proposed to aid the surgeon in deciding on the amount of parathyroid tissue to be resected. We examined the use of intraoperative monitoring of intact PTH in 47 patients operated upon for pHPT. The highly sensitive assay for intact PTH was modified to permit a total turn-around time from gland excision to obtained result of about 60 min. The correlation (r) between the results of the modified and the conventional method, which requires 24 h of incubation, was 0.98. At 15 min after removal of the parathyroid adenoma the levels of intact PTH had decreased by [mean (SD)] 85 (11)%. A decrease of 63% in intact PTH in patients with parathyroid adenoma predicted with 95% confidence the 4 patients with primary hyperplasia as not having parathyroid adenoma. We conclude that intraoperative measurement of intact PTH could be a valuable adjunct to surgical skill, especially for reoperative parathyroid surgery.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8145618     DOI: 10.1007/bf00206562

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  25 in total

1.  Usefulness and limits of quick intraoperative measurements of intact (1-84) parathyroid hormone in the surgical management of hyperparathyroidism: sequential measurements in patients with multiglandular disease.

Authors:  C A Proye; A Goropoulos; C Franz; B Carnaille; M Vix; J L Quievreux; G Couplet-Lebon; A Racadot
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

2.  Peroperative fat staining of frozen sections in primary hyperparathyroidism.

Authors:  O Ljungberg; S Tibblin
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

3.  Parathyroid surgery: the role of chief cell intracellular fat staining with osmium carmine in the intraoperative management of patients with primary hyperparathyroidism.

Authors:  J M Monchik; R Farrugia; C Teplitz; J Teplitz; S Brown
Journal:  Surgery       Date:  1983-12       Impact factor: 3.982

4.  Intraoperative parathormone level measurement in the management of hyperparathyroidism.

Authors:  C R McHenry; A Pollard; P G Walfish; I B Rosen
Journal:  Surgery       Date:  1990-10       Impact factor: 3.982

5.  Prospective analysis of intraoperative and postoperative urinary cyclic adenosine 3',5'-monophosphate levels to predict outcome of patients undergoing reoperations for primary hyperparathyroidism.

Authors:  G E Darling; S J Marx; A M Spiegel; G D Aurbach; J A Norton
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

6.  Study of intact (1-84) parathyroid hormone secretion in patients undergoing parathyroidectomy.

Authors:  C Davies; M J Demeure; A St John; A J Edis
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

7.  Intraoperative and postoperative PTH secretion mode in patients with hyperparathyroidism.

Authors:  S Fischer; D Flentje; C Kettelhack; J Schmidt-Gayk; H Buhr; C Herfarth
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

8.  Studies in patients with hyperparathyroidism using a new two-site immunochemiluminometric assay for circulating intact (1-84) parathyroid hormone.

Authors:  I R Curley; M H Wheeler; J P Aston; R C Brown; I Weeks; J S Woodhead
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

9.  Parathyroid adenomectomy under local anesthesia with intra-operative monitoring of UcAMP and/or 1-84 PTH.

Authors:  Y Chapuis; P Icard; Y Fulla; L Nonnenmacher; P Bonnichon; A Louvel; B Richard
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

10.  The rapid identification of "normal" parathyroid glands by the presence of intracellular fat.

Authors:  S I Roth; M J Gallagher
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

View more
  6 in total

1.  European endocrine surgery in the 150-year history of Langenbeck's Archives of Surgery.

Authors:  Henning Dralle; A Machens
Journal:  Langenbecks Arch Surg       Date:  2010-03-09       Impact factor: 3.445

2.  Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial.

Authors:  Anders Bergenfelz; Pia Lindblom; Sten Tibblin; Johan Westerdahl
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone.

Authors:  Johan Westerdahl; Anders Bergenfelz
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

4.  Effect on bone density of postoperative calcium and vitamin-D supplementation in patients with primary hyperparathyroidism: A retrospective study.

Authors:  Erik Nordenström; Johan Westerdahl; Anders Bergenfelz
Journal:  Langenbecks Arch Surg       Date:  2008-06-11       Impact factor: 3.445

5.  Serum levels of uric acid and diabetes mellitus influence survival after surgery for primary hyperparathyroidism: a prospective cohort study.

Authors:  Anders Bergenfelz; Anna Bladström; Mark Their; Erik Nordenström; Stig Valdemarsson; Johan Westerdahl
Journal:  World J Surg       Date:  2007-07       Impact factor: 3.352

6.  Surgery for patients with primary hyperparathyroidism and negative sestamibi scintigraphy--a feasibility study.

Authors:  Mark Thier; Erik Nordenström; Anders Bergenfelz; Johan Westerdahl
Journal:  Langenbecks Arch Surg       Date:  2009-06-23       Impact factor: 3.445

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.